1. Home
  2. AVDL vs SEMR Comparison

AVDL vs SEMR Comparison

Compare AVDL & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.69

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo SEMrush Holdings Inc.

SEMR

SEMrush Holdings Inc.

HOLD

Current Price

$11.82

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
SEMR
Founded
2015
2008
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
AVDL
SEMR
Price
$21.69
$11.82
Analyst Decision
Buy
Hold
Analyst Count
8
6
Target Price
$19.14
$12.75
AVG Volume (30 Days)
1.6M
2.9M
Earning Date
03-02-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$248,517,000.00
$428,627,000.00
Revenue This Year
$65.47
$20.35
Revenue Next Year
$30.88
$14.87
P/E Ratio
N/A
N/A
Revenue Growth
79.88
19.87
52 Week Low
$6.38
$6.56
52 Week High
$23.57
$18.74

Technical Indicators

Market Signals
Indicator
AVDL
SEMR
Relative Strength Index (RSI) 63.88 58.09
Support Level $21.52 $11.84
Resistance Level $21.69 $11.94
Average True Range (ATR) 0.06 0.03
MACD -0.01 -0.04
Stochastic Oscillator 66.67 14.29

Price Performance

Historical Comparison
AVDL
SEMR

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

Share on Social Networks: